알피바이오

314140KOSDAQ

62.5 / 100

Reference Date: 2026-09-08

Financial Score27.0 / 40

News Sentiment18.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Alpibio produces and sells pharmaceuticals (cold medicine, pain relievers) and health functional foods (omega-3, diet supplements) in various forms, including soft capsules, through OEM/ODM models. It holds over 60% of the domestic pharmaceutical soft capsule market and is rapidly growing its health functional food sales, driven by market expansion and R&D efforts with numerous patents.

Number of Employees

534people

Average Salary

37.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

11.44Industry Average 15.005.0Point

In line with industry avg

PBR

0.50Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

4.47Industry Average 8.002.5Point

Below industry avg

Debt Ratio

4.34Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.0% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲361.4% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 3.1% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 4Neutral 1Negative 0Average Sentiment Score 74

Positive
[르포] 부스마다 북적…K건기식, 원료·제형 차별화로 승부
알피바이오의 차별화된 제형 기술이 국제 전시회에서 주목받아 긍정적인 시장 반응을 이끌어냈다.
Positive
알피바이오, 태국 비타푸드 아시아 첫 참가
알피바이오의 아시아 첫 참가로 글로벌 OEM/ODM 수주 확대 기대감 증가.
Positive
알피바이오 노미선 상무, 식약처장 표창 수상
알피바이오의 노미선 상무가 식품의약품안전처 표창 수상으로 기업의 국제 경쟁력 강화에 기여한 것으로 평가됩니다.

Detailed Momentum

52-week position3.0Point

52w lower range (38%)

Current 6,190Won52-week high 8,01052-week low 5,060

1-month return3.0Point

1m 0.16% (flat)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14